4.6 Article

Protein content of blood-derived extracellular vesicles: An approach to the pathophysiology of cerebral hemorrhage

期刊

FRONTIERS IN CELLULAR NEUROSCIENCE
卷 16, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fncel.2022.1058546

关键词

blood; extracellular vesicles; intracerebral hemorhage; proteomics; rat

向作者/读者索取更多资源

Extracellular vesicles (EVs) play a role in intercellular communication and can serve as biomarkers for disease processes. In the context of intracerebral hemorrhage, studying the number and protein content of circulating EVs can provide insights into the underlying biological mechanisms of damage and repair, aiding in the identification of potential therapeutic targets.
Introduction: Extracellular vesicles (EVs) participate in cell-to-cell paracrine signaling and can be biomarkers of the pathophysiological processes underlying disease. In intracerebral hemorrhage, the study of the number and molecular content of circulating EVs may help elucidate the biological mechanisms involved in damage and repair, contributing valuable information to the identification of new therapeutic targets.Methods: The objective of this study was to describe the number and protein content of blood-derived EVs following an intracerebral hemorrhage (ICH). For this purpose, an experimental ICH was induced in the striatum of Sprague-Dawley rats and EVs were isolated and characterized from blood at baseline, 24 h and 28 days. The protein content in the EVs was analyzed by mass spectrometric data-dependent acquisition; protein quantification was obtained by sequential window acquisition of all theoretical mass spectra data and compared at pre-defined time points.Results: Although no differences were found in the number of EVs, the proteomic study revealed that proteins related to the response to cellular damage such as deubiquitination, regulation of MAP kinase activity (UCHL1) and signal transduction (NDGR3), were up-expressed at 24 h compared to baseline; and that at 28 days, the protein expression profile was characterized by a higher content of the proteins involved in healing and repair processes such as cytoskeleton organization and response to growth factors (COR1B) and the regulation of autophagy (PI42B).Discussion: The protein content of circulating EVs at different time points following an ICH may reflect evolutionary changes in the pathophysiology of the disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Dentistry, Oral Surgery & Medicine

Quantitative proteomics in medication-related osteonecrosis of the jaw: A proof-of-concept study

Alejandro Lorenzo-Pouso, Susana B. Bravo, Javier Carballo, Maria del Pilar Chantada-Vazquez, Jose Bagan, Leticia Bagan, Cintia M. Chamorro-Petronacci, Mercedes Conde-Amboage, Rafael Lopez-Lopez, Abel Garcia-Garcia, Mario Perez-Sayans

Summary: This study investigated the salivary proteome in MRONJ patients and identified differentially expressed proteins. Three prioritized proteins were identified, which may serve as a potential biomarker panel for the prediction or diagnosis of MRONJ.

ORAL DISEASES (2023)

Article Biochemistry & Molecular Biology

Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma

Lucia Trilla-Fuertes, Angelo Gamez-Pozo, Guillermo Prado-Vazquez, Rocio Lopez-Vacas, Andrea Zapater-Moros, Elena Lopez-Camacho, Maria Lumbreras-Herrera, Virtudes Soriano, Fernando Garicano, Ma Jose Lecumberri, Maria Rodriguez de la Borbolla, Margarita Majem, Elisabeth Perez-Ruiz, Maria Gonzalez-Cao, Juana Oramas, Alejandra Magdaleno, Joaquin Fra, Alfonso Martin-Carnicero, Monica Corral, Teresa Puertolas, Ricardo Ramos, Juan Angel Fresno Vara, Enrique Espinosa

Summary: Immunotherapy based on anti-PD1 antibodies has improved outcomes in advanced melanoma, but predicting response to treatment remains a challenge. This study used probabilistic graphical models and classificatory algorithms to classify melanoma samples, and found that gene expression data can be grouped into immune and molecular layers of information. The immune layer classification was able to distinguish responders from non-responders to immunotherapy in a new cohort, indicating its potential as a useful tool for clinicians in identifying patients who will benefit from immunotherapy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Genetics & Heredity

Client Applications and Server-Side Docker for Management of RNASeq and/or VariantSeq Workflows and Pipelines of the GPRO Suite

Ahmed Ibrahem Hafez, Beatriz Soriano, Aya Allah Elsayed, Ricardo Futami, Raquel Ceprian, Ricardo Ramos-Ruiz, Genis Martinez, Francisco Jose Roig, Miguel Angel Torres-Font, Fernando Naya-Catala, Josep Alvar Calduch-Giner, Lucia Trilla-Fuertes, Angelo Gamez-Pozo, Vicente Arnau, Jose Maria Sempere-Luna, Jaume Perez-Sanchez, Toni Gabaldon, Carlos Llorens

Summary: The GPRO suite is an ongoing bioinformatic project for the analysis of -omics data. It introduces a client- and server-side solution for comparative transcriptomics and variant analysis. The client-side includes two Java applications, RNASeq and VariantSeq, which manage pipelines and workflows using common command line tools. The server-side, named GPRO Server-Side, hosts all dependencies and requires a Linux operating system, PHP, SQL, Python, bash scripting, and third-party software. The solution offers both desktop and web applications, with step-by-step and pipeline modes for execution. It also features an experimental support system called GENIE, with a chatbot assistant and expert system for troubleshooting and recommendations.
Article Medicine, General & Internal

Proteomics Characterization of Clear Cell Renal Cell Carcinoma

Jesus Miranda-Poma, Lucia Trilla-Fuertes, Rocio Lopez-Vacas, Elena Lopez-Camacho, Eugenia Garcia-Fernandez, Ana Pertejo, Maria Lumbreras-Herrera, Andrea Zapater-Moros, Mariana Diaz-Almiron, Antje Dittmann, Juan Angel Fresno Vara, Enrique Espinosa, Pilar Gonzalez-Peramato, Alvaro Pinto-Marin, Angelo Gamez-Pozo

Summary: This study aimed to explore the tumor proteome of patients diagnosed with localized clear cell renal cancer (ccRCC) and treated with surgery. A total of 165 FFPE tumor samples were analyzed, leading to the identification and quantification of 3091 proteins. Two proteomics subtypes of ccRCC (CC1 and CC2) were identified, each characterized by specific protein expression patterns and functional features. The knowledge gained from this study could potentially aid in the development of new drugs targeting subtype-specific deregulated pathways.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Biochemistry & Molecular Biology

β Boswellic Acid Blocks Articular Innate Immune Responses: An In Silico and In Vitro Approach to Traditional Medicine

Eloi Franco-Trepat, Ana Alonso-Perez, Maria Guillan-Fresco, Miriam Lopez-Fagundez, Andres Pazos-Perez, Antia Crespo-Golmar, Susana Belen Bravo, Veronica Lopez-Lopez, Alberto Jorge-Mora, Jose P. Ceron-Carrasco, Ana Lois Iglesias, Rodolfo Gomez

Summary: Osteoarthritis is a progressive rheumatic disease characterized by joint inflammation and degradation. The compound beta boswellic acid (BBA) has shown potential in reducing cartilage loss by inhibiting TLR4 and IL1R signaling in OA joint cells. This study presents solid evidence of BBA's therapeutic properties, suggesting its potential as a treatment for OA after further clinical evaluations.

ANTIOXIDANTS (2023)

Article Biochemistry & Molecular Biology

The Relationship between the Expression of GATA4 and GATA6 with the Clinical Characteristics and Prognosis of Resectable Pancreatic Adenocarcinoma

Victoria Heredia-Soto, Laura Gutierrez-Sainz, Ismael Ghanem, Laura Guerra, Elena Palacios, Marta de Uribe, Lucia Trilla-Fuertes, Maria de Miguel, Paloma Cejas, Laura Medina, Jose Miguel Calderon, David Vinal, Marta Mendiola, Jaime Feliu

Summary: This study aimed to determine the clinical utility of GATA4 and GATA6 expression determined by immunohistochemistry (IHC) in resected pancreatic ductal adenocarcinoma (PDAC) patients. The results showed that the expression of GATA4 and GATA6 was related to clinicopathologic variables and prognosis. GATA6 expression was associated with the classic molecular subtype, while its absence was related to the basal-like molecular subtype. The determination of GATA4 and GATA6 expression by IHC is feasible and can provide complementary clinical and prognostic information to improve the stratification of PDAC patients.

BIOMEDICINES (2023)

Article Oncology

Utility of CYP2D6 copy number variants as prognostic biomarker in localized anal squamous cell carcinoma

Lucia Trilla-Fuertes, Angelo Gamez-Pozo, Miguel Nogue, Isabel Busquier, Fernando Arias, Fernando Lopez-Campos, Ana Fernandez-Montes, Ana Ruiz, Concepcion Velazquez, Celia Martin-Bravo, Elisabeth Perez-Ruiz, Elena Asensio, Xavier Hernandez-Yague, Aline Rodrigues, Ismael Ghanem, Rocio Lopez-Vacas, Ahmed Hafez, Pedro Arias, Irene Dapia, Mario Solis, Antje Dittmann, Ricardo Ramos, Carlos Llorens, Joan Maurel, Angel Campos-Barros, Juan Angel Fresno Vara, Jaime Feliu

Summary: This study aimed to identify biomarkers for personalized treatments and improvement of therapeutic outcomes in anal squamous cell carcinoma (ASCC). The researchers analyzed tumor samples from ASCC patients through whole-exome sequencing and identified genes associated with disease-free survival. The presence of duplications in the CYP2D6 gene was found to be a biomarker of worse disease-free survival. Proteomics analysis also suggested mitochondria and mitochondrial cell-cycle genes as potential therapeutic targets.

CANCER (2023)

Article Multidisciplinary Sciences

Neck CT angiography in acute stroke: An open window for fast detection of COVID-19 lung involvement? Applicability in telemedicine

Jorge Ucles, Emilio Cuesta, Ricardo Rigual, Jorge Rodriguez-Pardo, Gerardo Ruiz-Ares, Pedro Navia, Andres Fernandez-Prieto, Alberto Alvarez-Muelas, Maria Alonso de Lecinana, Blanca Fuentes

Summary: This study compared the predictive value of neck CTA source images and conventional chest CT to rule out SARS-CoV-2 lung infection. The results showed that neck CTA accurately identified COVID-19-associated lung abnormalities in acute stroke patients. Mobile applications for CO-RADS evaluations had a predictive value similar to traditional platforms.

PLOS ONE (2023)

Article Oncology

A Novel Molecular Analysis Approach in Colorectal Cancer Suggests New Treatment Opportunities

Elena Lopez-Camacho, Guillermo Prado-Vazquez, Daniel Martinez-Perez, Maria Ferrer-Gomez, Sara Llorente-Armijo, Rocio Lopez-Vacas, Mariana Diaz-Almiron, Angelo Gamez-Pozo, Juan Angel Fresno Vara, Jaime Feliu, Lucia Trilla-Fuertes

Summary: This study aimed to deepen the molecular characterization of colorectal cancer (CRC) using a novel analysis approach. Three layers of information were identified: adhesion, immune, and molecular. The molecular layer divided CRC into stem cell, Wnt, metabolic, and extracellular groups, suggesting possible therapeutic targets. Immune-high patients may benefit from immunotherapy and viral mimicry-related therapies.

CANCERS (2023)

Article Immunology

Brain and immune system-derived extracellular vesicles mediate regulation of complement system, extracellular matrix remodeling, brain repair and antigen tolerance in Multiple sclerosis

Gabriel Torres Iglesias, Mireya Fernandez-Fournier, Lucia Botella, Dolores Piniella, Fernando Laso-Garcia, Mari Carmen Gomez-de Frutos, Beatriz Chamorro, Inmaculada Puertas, Antonio Tallon Barranco, Blanca Fuentes, Maria Alonso de Lecinana, Elisa Alonso-Lopez, Susana B. Bravo, Maria Eugenia Miranda-Carus, Ana Montero-Calle, Rodrigo Barderas, Exuperio Diez-Tejedor, Maria Gutierrez-Fernandez, Laura Otero-Ortega

Summary: Blood extracellular vesicles (EVs) derived from T cells and neurons have been identified as specific biomarkers in multiple sclerosis (MS). Proteomic analysis revealed MS-associated proteins in these EVs, which correlated with disease activity.

BRAIN BEHAVIOR AND IMMUNITY (2023)

Article Oncology

Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma

Lucia Trilla-Fuertes, Angelo Gamez-Pozo, Guillermo Prado-Vazquez, Rocio Lopez-Vacas, Virtudes Soriano, Fernando Garicano, M. Jose Lecumberri, Maria Rodriguez de la Borbolla, Margarita Majem, Elisabeth Perez-Ruiz, Maria Gonzalez-Cao, Juana Oramas, Alejandra Magdaleno, Joaquin Fra, Alfonso Martin-Carnicero, Monica Corral, Teresa Puertolas, Ricardo Ramos-Ruiz, Antje Dittmann, Paolo Nanni, Juan Angel Fresno Vara, Enrique Espinosa

Summary: Immunotherapy has improved survival in advanced melanoma patients, but not all patients respond to this treatment. This study analyzed clinical samples from melanoma patients treated with immunotherapy and identified proteins involved in protein processing, antigen presentation, immune, and inflammatory responses that play a role in the response to immunotherapy. A prognostic signature was also established to predict the response to immunotherapy.

CANCERS (2023)

Article Oncology

Clinico-Pathological Features, Outcomes and Impacts of COVID-19 Pandemic on Patients with Early-Onset Colorectal Cancer: A Single-Institution Experience

Daniel Martinez-Perez, David Vinal, Jesus Pena-Lopez, Diego Jimenez-Bou, Iciar Ruiz-Gutierrez, Sergio Martinez-Recio, Maria Alameda-Guijarro, Antonio Rueda-Lara, Gema Martin-Montalvo, Ismael Ghanem, Ana Belen Custodio, Lucia Trilla-Fuertes, Angelo Gamez-Pozo, Antonio Barbachano, Javier Rodriguez-Cobos, Pilar Bustamante-Madrid, Asuncion Fernandez-Barral, Aurora Burgos, Maria Isabel Prieto-Nieto, Laura Guerra Pastrian, Jose Manuel Gonzalez-Sancho, Alberto Munoz, Jaime Feliu, Nuria Rodriguez-Salas

Summary: The rising incidence of colorectal cancer (CRC) among young patients is alarming. This study included all patients with pathologically confirmed diagnoses of CRC at Hospital Universitario La Paz from October 2016 to December 2021. Among the 1475 CRC patients, 80 (5.4%) had early-onset CRC (EOCRC). EOCRC had more aggressive pathological features and higher prevalence of certain characteristics compared to later-onset CRC. Metastatic EOCRC patients had significantly longer overall survival (OS) than the older cohort. More patients with COVID-19 were diagnosed with metastatic disease after the lockdown.

CANCERS (2023)

暂无数据